Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2002 1
2009 1
2010 1
2013 1
2015 1
2016 5
2017 3
2019 3
2020 4
2021 4
2022 6
2023 1
2024 2
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study.
de Wild SR, de Munck L, Simons JM, Verloop J, van Dalen T, Elkhuizen PHM, Houben RMA, van Leeuwen AE, Linn SC, Pijnappel RM, Poortmans PMP, Strobbe LJA, Wesseling J, Voogd AC, Boersma LJ. de Wild SR, et al. Among authors: verloop j. Lancet Oncol. 2022 Sep;23(9):1201-1210. doi: 10.1016/S1470-2045(22)00482-X. Epub 2022 Aug 8. Lancet Oncol. 2022. PMID: 35952707
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Bandera EV, Barile M, Barkardottir RB, Barrowdale D, Beckmann MW, Benitez J, Berchuck A, Bisogna M, Bjorge L, Blomqvist C, Blot W, Bogdanova N, Bojesen A, Bojesen SE, Bolla MK, Bonanni B, Børresen-Dale AL, Brauch H, Brennan P, Brenner H, Bruinsma F, Brunet J, Buhari SA, Burwinkel B, Butzow R, Buys SS, Cai Q, Caldes T, Campbell I, Cannioto R, Chang-Claude J, Chiquette J, Choi JY, Claes KBM; GEMO Study Collaborators; Cook LS, Cox A, Cramer DW, Cross SS, Cybulski C, Czene K, Daly MB, Damiola F, Dansonka-Mieszkowska A, Darabi H, Dennis J, Devilee P, Diez O, Doherty JA, Domchek SM, Dorfling CM, Dörk T, Dumont M, Ehrencrona H, Ejlertsen B, Ellis S; EMBRACE; Engel C, Lee E, Evans DG, Fasching PA, Feliubadalo L, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Foretova L, Fostira F, Foulkes WD, Fridley BL, Friedman E, Frost D, Gambino G, Ganz PA, Garber J, García-Closas M, Gentry-Maharaj A, Ghoussaini M, Giles GG, Glasspool R, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Goode EL, Goodman MT, Gree… See abstract for full author list ➔ Lawrenson K, et al. Nat Commun. 2025 Sep 8;16(1):8237. doi: 10.1038/s41467-025-63507-x. Nat Commun. 2025. PMID: 40925936 Free PMC article. No abstract available.
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.
Schreurs MAC, Schmidt MK, Hollestelle A, Schaapveld M, van Asperen CJ, Ausems MGEM, van de Beek I, Broekema MF, Margriet Collée J, van der Hout AH, van Kaam KJAF, Komdeur FL, Mensenkamp AR, Adank MA, Hooning MJ; Hereditary Breast and Ovarian Cancer Research Group Netherlands. Schreurs MAC, et al. Genet Med. 2024 Sep;26(9):101171. doi: 10.1016/j.gim.2024.101171. Epub 2024 May 31. Genet Med. 2024. PMID: 38828701 Free article.
Cancer risk after in utero exposure to diethylstilbestrol.
Boekel NB, Verloop J, van Boven HH, van Erp EJM, Schrijver L, Rookus MA, van Leeuwen FE. Boekel NB, et al. Among authors: verloop j. Eur J Epidemiol. 2025 Jun;40(6):659-668. doi: 10.1007/s10654-025-01234-9. Epub 2025 May 28. Eur J Epidemiol. 2025. PMID: 40426001
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.
Stroot IAS, Bart J, Hollema H, Wagner MM, Yigit R, van Doorn HC, de Hullu JA, Gaarenstroom KN, van Beurden M, van Lonkhuijzen LRCW, Slangen BFM, Zweemer RP, Gómez Garcia EB, Ausems MGEM, Komdeur FL, van Asperen CJ, Adank MA, Wevers MR, Hooning MJ; HEBON Investigators; Mourits MJE, de Bock GH. Stroot IAS, et al. J Natl Cancer Inst. 2025 Apr 1;117(4):719-727. doi: 10.1093/jnci/djae300. J Natl Cancer Inst. 2025. PMID: 39579093
Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020-2023, using registry data and questionnaires.
Eijkelboom AH, van Beek EJA, Stam MR, Westhoff P, van Maaren MC, Sattler MGA, Bantema-Joppe EJ, Verheij M, van den Bongard DHJG, Siesling S; NABON-COVID-19 Consortium and the COVID and Cancer-NL Consortium. Eijkelboom AH, et al. Radiat Oncol. 2025 Jun 12;20(1):99. doi: 10.1186/s13014-025-02669-w. Radiat Oncol. 2025. PMID: 40506770 Free PMC article.
Worse prognosis for breast cancer diagnosed in advanced pregnancy and shortly postpartum: an update of the Dutch pregnancy-associated breast cancer cohort.
Bakhuis CFJ, Preković S, Suelmann BBM, Verloop J, Westenend PJ, Linn SC, van Diest PJ, van der Wall E, van Dooijeweert C. Bakhuis CFJ, et al. Among authors: verloop j. Breast Cancer Res Treat. 2025 Nov;214(2):191-204. doi: 10.1007/s10549-025-07806-3. Epub 2025 Aug 12. Breast Cancer Res Treat. 2025. PMID: 40796679 Free PMC article.
Cancer risk in DES daughters.
Verloop J, van Leeuwen FE, Helmerhorst TJ, van Boven HH, Rookus MA. Verloop J, et al. Cancer Causes Control. 2010 Jul;21(7):999-1007. doi: 10.1007/s10552-010-9526-5. Epub 2010 Mar 4. Cancer Causes Control. 2010. PMID: 20204493 Free PMC article.
37 results